A hepatitis C (HCV) cure is associated with changes in lipids and inflammatory biomarkers, but its impact on clinical endpoints among treated human immunodeficiency virus (HIV)/HCV coinfected persons is unclear.
Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment / Mocroft, A., Lundgren, J., Gerstoft, J., Rasmussen, L.D., Bhagani, S., Aho, I., Pradier, C., Bogner, J.R., Mussini, C., Uberti Foppa, C., Maltez, F., Laguno, M., Wandeler, G., Falconer, K., Trofimova, T., Borodulina, E., Jevtovic, D., Bakowska, E., Kase, K., Kyselyova, G., et al.. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 70:10(2020), pp. 2131-2140. [10.1093/cid/ciz601]
Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment
Mussini, Cristina;
2020
Abstract
A hepatitis C (HCV) cure is associated with changes in lipids and inflammatory biomarkers, but its impact on clinical endpoints among treated human immunodeficiency virus (HIV)/HCV coinfected persons is unclear.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ciz601.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
674.35 kB
Formato
Adobe PDF
|
674.35 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
